Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
Public ClinicalTrials.gov record NCT01824303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Study identification
- NCT ID
- NCT01824303
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Interventions
- LiRIS 400 mg Drug
- LiRIS Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2013
- Primary completion
- Oct 31, 2014
- Completion
- Nov 30, 2014
- Last update posted
- Jan 25, 2016
2013 – 2014
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Citrus Valley Medical Research , Inc. | Glendora | California | 91741 | — |
| Atlantic Urological Associates | Daytona Beach | Florida | 32114 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| The UrogynecologyCenter, LLC | Overland Park | Kansas | 66209-2002 | — |
| Female Pelvic Medicine & Urogynecology Institute of MI | Grand Rapids | Michigan | 49503 | — |
| William Beaumont Hospitals | Royal Oak | Michigan | 48073 | — |
| North Shore - Long Island Jewish Heath System - Monter Cancer Center | New Hyde Park | New York | 11040 | — |
| Premier Medical Group of the Hudson Valley PC | Newburgh | New York | 12550 | — |
| Premier Medical Group of the Hudson Valley PC | Poughkeepsie | New York | 12601 | — |
| Alliance Urology Specialists, PA | Greensboro | North Carolina | 27403 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27103 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Volunteer Research Group, University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01824303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 25, 2016 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01824303 live on ClinicalTrials.gov.